Identification of HCV genotypes in HCV infected blood donors

Zohreh Sharifi1, Mahmood Mahmoodian Shooshtari, Fahimeh Rangbar Kermani

  • 1Research center, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran.

Insights

Hepatitis C virus (HCV) genotype distribution was similar in blood donors and patients. Genotypes 1a, 3a, and 1b were most common, highlighting their prevalence in chronic liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection is a primary cause of chronic liver disease and cirrhosis.
  • Multiple HCV genotypes exist, with geographic variations in prevalence.
  • Understanding genotype distribution is crucial for disease management and epidemiology.

Purpose of the Study:

  • To identify and compare the distribution of HCV genotypes in blood donors and patients with hepatitis C.
  • To determine the most prevalent HCV genotypes within these populations.

Main Methods:

  • A cross-sectional study involving 167 serum samples (103 blood donors, 64 patients).
  • HCV genotyping performed using type-specific primers targeting the viral core region.
  • Statistical analysis to assess genotype distribution and associations.

Main Results:

  • Genotype 1a was the most frequent in both groups (51.5% blood donors, 53.1% patients).
  • Genotypes 3a and 1b were also prevalent (3.9% and 37.9% in blood donors; 25% and 15.6% in patients, respectively).
  • No significant association found between patient's place of infection and HCV genotype.

Conclusions:

  • The distribution of HCV genotypes is similar between blood donors and patients.
  • Hepatitis C virus genotypes 1a, 3a, and 1b are dominant in the studied populations.
  • Findings contribute to understanding HCV epidemiology and regional genotype patterns.